BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 25550510)

  • 1. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor
    Yang Y; Xu X; Wu H; Yang J; Chen J; Morisseau C; Hammock BD; Bettaieb A; Zhao L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
    Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
    Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Epoxide Hydrolase Inhibition by
    Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
    Frömel T; Hu J; Fleming I
    Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory ω-3 endocannabinoid epoxides.
    McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
    Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
    Bettaieb A; Nagata N; AbouBechara D; Chahed S; Morisseau C; Hammock BD; Haj FG
    J Biol Chem; 2013 May; 288(20):14189-14199. PubMed ID: 23576437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
    Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
    J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Zhang CH; Zheng L; Gui L; Lin JY; Zhu YM; Deng WS; Luo M
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):118-125. PubMed ID: 29031875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.
    Wagner K; Gilda J; Yang J; Wan D; Morisseau C; Gomes AV; Hammock BD
    Behav Brain Res; 2017 May; 326():69-76. PubMed ID: 28259677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
    Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
    Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase: A potential target for metabolic diseases.
    He J; Wang C; Zhu Y; Ai D
    J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma.
    Leineweber CG; Pietzner A; Zhang IW; Blessin UB; Rothe M; Schott E; Schebb NH; Weylandt KH
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice.
    Ludwig T; Worsch S; Heikenwalder M; Daniel H; Hauner H; Bader BL
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1140-56. PubMed ID: 23482450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
    Wagner K; Yang J; Inceoglu B; Hammock BD
    J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.